Clinical Trial: Efficacy and Safety of Compound Raceanisodamine Eye Drops in the Treatment of Asthenopia in Chinese Adolescents with Refractive Error: A Single-Center, Randomized, Open-Label, Positive Parallel-Controlled Study (China)

Posted On: 2026-09-21

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Compound Raceanisodamine Eye Drops in the Treatment of Asthenopia in Chinese Adolescents with Refractive Error: A Single-Center, Randomized, Open-Label, Positive Parallel-Controlled Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132768

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: Eye Hospital, Wenzhou Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340512

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Efficacy and Safety of Compound Raceanisodamine Eye Drops in the Treatment of Asthenopia in Chinese Adolescents with Refractive Error: A Single-Center, Randomized, Open-Label, Positive Parallel-Controlled Study (China)